M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Return to Archives
New Search
Lannett Company Inc secures FDA approval for Hydromorphone Hydrochloride Tablets
Generic pharmaceutical products provider Lannett Company Inc (NYSE AMEX:LCI) declared on Thursday the receipt of approval from the US Food and Drug Administration (FDA) of its Abbreviated New Drug Applications (ANDAs) for Hydromorphone Hydrochloride Tablets USP, 2 mg, 4 mg and 8 mg.
The...
If you want to view the full text of this story, you must first purchase archive retrieval credits.